Meeting to be held in Boston on April 15 hosted by Stephens.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRIX:
- Nurix Therapeutics price target lowered to $30 from $35 at UBS
- Hold Rating for Nurix Therapeutics Amid Competitive Challenges and Strategic Uncertainties
- Nurix Therapeutics price target lowered to $32 from $35 at Oppenheimer
- Nurix Therapeutics price target lowered to $25 from $32 at Wells Fargo
- Nurix Therapeutics price target lowered to $35 from $36 at Stifel